Tanezumab Reduces Osteoarthritic Hip Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
Author:
Affiliation:
1. Pfizer Inc.; Groton; Connecticut
2. Altoona Center for Clinical Research, Duncansville, Pennsylvania, and University of Pennsylvania School of Medicine; Philadelphia
3. Stamford Therapeutics Consortium; Stamford; Connecticut
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference28 articles.
1. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II;Lawrence;Arthritis Rheum,2008
2. Primary osteoarthritis of the hip: etiology and epidemiology;Hoaglund;J Am Acad Orthop Surg,2001
3. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines;Zhang;Osteoarthritis Cartilage,2008
4. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study;Johnsen;Arch Intern Med,2005
5. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics;Whelton;Am J Ther,2000
Cited by 111 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoclonal antibodies as analgesia of chronic low back pain: a systematic review and meta-analysis of efficacy and safety;Annals of Clinical and Experimental Neurology;2024-07-08
2. IUPHAR review: Navigating the role of preclinical models in pain research;Pharmacological Research;2024-02
3. Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis;Clinical Drug Investigation;2023-07
4. Meteorin Alleviates Paclitaxel-Induced Peripheral Neuropathic Pain in Mice;The Journal of Pain;2023-04
5. Different Dosage Regimens of Tanezumab for the Treatment of Chronic Low Back Pain: A Meta-analysis of Randomized Controlled Trials;Clinical Neuropharmacology;2022-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3